Aardvark Therapeutics, Inc. (AARD)

Aardvark Therapeutics Statistics

Total Valuation

AARD has a market cap or net worth of $211.98 million. The enterprise value is $70.80 million.

Market Cap	211.98M
Enterprise Value	70.80M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

AARD has 21.70 million shares outstanding. The number of shares has increased by 170.95% in one year.

Current Share Class	21.70M
Shares Outstanding	21.70M
Shares Change (YoY)	+170.95%
Shares Change (QoQ)	+64.39%
Owned by Insiders (%)	14.49%
Owned by Institutions (%)	17.14%
Float	11.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.55
P/TBV Ratio	1.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.04, with a Debt / Equity ratio of 0.00.

Current Ratio	14.04
Quick Ratio	13.76
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.09% and return on invested capital (ROIC) is -22.98%.

Return on Equity (ROE)	-33.09%
Return on Assets (ROA)	-21.76%
Return on Invested Capital (ROIC)	-22.98%
Return on Capital Employed (ROCE)	-29.79%
Revenue Per Employee	n/a
Profits Per Employee	-$1.67M
Employee Count	22
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	12.28
200-Day Moving Average	n/a
Relative Strength Index (RSI)	35.80
Average Volume (20 Days)	50,864

Short Selling Information

The latest short interest is 622,706, so 2.87% of the outstanding shares have been sold short.

Short Interest	622,706
Short Previous Month	663,811
Short % of Shares Out	2.87%
Short % of Float	5.58%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-40.86M
Pretax Income	-13.85M
Net Income	-36.64M
EBITDA	-40.83M
EBIT	-40.86M
Earnings Per Share (EPS)	-$3.41

Balance Sheet

The company has $141.82 million in cash and $645,000 in debt, giving a net cash position of $141.18 million or $6.51 per share.

Cash & Cash Equivalents	141.82M
Total Debt	645,000
Net Cash	141.18M
Net Cash Per Share	$6.51
Equity (Book Value)	136.93M
Book Value Per Share	6.31
Working Capital	134.46M

Cash Flow

In the last 12 months, operating cash flow was -$32.91 million and capital expenditures -$102,000, giving a free cash flow of -$33.02 million.

Operating Cash Flow	-32.91M
Capital Expenditures	-102,000
Free Cash Flow	-33.02M
FCF Per Share	-$1.52

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AARD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-170.95%
Shareholder Yield	-170.95%
Earnings Yield	-17.28%
FCF Yield	-15.58%

Analyst Forecast

The average price target for AARD is $32.80, which is 235.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.80
Price Target Difference	235.72%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1